Global Tumor Ablation Market: Awareness Programs and Improvement of Cancer Treatment Service Initiatives Improving the Growth of Tumor Ablation

Global Tumor Ablation Market

Tumor ablation is an innovative treatment of tumors and cancerous cells. It is a minimally invasive mode of treatment wherein tissues are exposed to thermal energy till the point they reach cytotoxic levels, i.e. -400C or 600C. This technique is common in the treatment of liver, kidney, lung and bone. This method of treatment is designed for patients who haven’t had effective treatment conclusions in chemotherapy/radiotherapy or are not able to undergo surgical treatments.

Access Full Report at

Tumor ablation market is growing due to increasing prevalence of cancer patients and rising number of hospitals, surgical and ablation centers; the effects of these factors are mentioned below:

  • Increasing prevalence of cancer patients: One of the major reasons behind the increase in the adoption rate of tumor ablation treatment methods is an obvious one, i.e. an increase in the levels of population suffering from cancer. This rise in the patient pool means that this population group requires effective treatment solution. Although, there are various treatment alternatives available in the market but recently the need for minimally invasive method of treatments is on the rise which bodes well for tumor ablation. One of the other benefits is the reduction of negative effects on the human body as chemotherapy/radiotherapy comes with large numbers of negative side-effects
  • Rising number of hospitals, surgical and ablation centers: Increasing availability of hospitals, surgical and ablation centers which provide this innovative method of treatment is helping improve the rate at which the market is growing as many patients have a lack of knowledge regarding this treatment method. This also has improved the availability of the treatment in the market which is giving rise to better adoption rate by the patients

Expansion and strategic acquisitions utilized by the manufacturers:

  • In March 2016, NeuWave Medical announced the acquisition by Ethicon, a company operating under the Johnson & Johnson group of companies. This acquisition will help in expansion of product offerings, development and innovations for the combined companies along with the expansion of their global presence. This acquisition will improve the ablation modes of treatment offerings of Ethicon as they look to improve the innovations in surgical methods of treatment available in the market
  • In January 2016, Medtronic announced that they had acquired Baylis Medical’s “OsteoCool” device after it had received US FDA’s 510(k) clearance. The device is designed for treatment of cancers that have metastasized to the spine of patients. This method reduces the pain that patients suffer during the treatment process in a single process. This acquisition is set to improve the rate of availability of technology provided by Medtronic in the market especially for spinal tumor ablation

The market is segmented on the basis of type as tumor ablation systems, image guidance products, accessories; cancer type is categorized into liver cancer, brain cancer, lung cancer, bone cancer, kidney cancer, pancreatic cancer, breast cancer, others; mode of treatment is segmented into surgical, laparoscopic, percutaneous; end users is categorized as hospitals, oncology clinics, others.

“According to Data Bridge Market Research, global tumor ablation market is expected to be growing at a substantial CAGR of 9.8% during the forecast period of 2017 to 2024”

Some of the major players operating in market are Medtronic, Boston Scientific Corporation, Abbott, Galil Medical Inc., Perseon Corporation, NeuWave Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S, SonaCare Medical, LLC, DFINE, Inc., Misonix, BVM Medical Limited, AngioDynamics, COMSOL Inc, EDAP TMS and HealthTronics, Inc.

The market is growing at a substantial rate because of the various awareness programs and informative initiatives presented by the governments, authorities, medical centers have improved the knowledge amongst the world regarding the availability of alternative methods of treatment for cancer, instead of chemotherapy/radiotherapy. The combined activities of these authorities have increased the rate at which these services are being provided to patients with increasing patients preferring this method over surgeries or chemotherapy.